Literature DB >> 23168385

Amphiphilic starlike dextran wrapped superparamagnetic iron oxide nanoparticle clsuters as effective magnetic resonance imaging probes.

Hongying Su1, Yanhong Liu, Dan Wang, Changqiang Wu, Chunchao Xia, Qiyong Gong, Bin Song, Hua Ai.   

Abstract

Starlike polymers have been widely used in various fields, such as tissue engineering, imaging, gene and drug delivery because of their unique structures and properties. Dextran has long been used as a temporary plasma substitute because of its excellent biocompatibility. In this study, starlike polysaccharide with multiple dextran arms was designed and developed by attaching dextran to a β-cyclodextrin core through click chemistry. Next, starlike dextran was modified with aliphatic chains and these amphiphilic polymers can self-assemble into nanoscale micelles in water, and their critical micelle concentration values (3.7 × 10(-8) M) are much lower comparing to its linear analogs (1.7 × 10(-7) M), resulting in more stable nanostructures in aqueous environment. These micelles can encapsulate multiple superparamagnetic iron oxide nanoparticles and forming clustering particle nanostructures in water, and the resulting nanocomposites have a high T(2) relaxivity of 436.8 Fe mm(-1) s(-1) under a 1.5T clinical magnetic resonance imaging (MRI) scanner. Further, dual functional probes were developed by loading both superparamagnetic iron oxide nanoparticles and small molecule anticancer drug doxorubicin into polymeric micelles. Multidrug-resistant breast cancer cells MCF-7/Adr treated with these probes can be characterized under MRI.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23168385     DOI: 10.1016/j.biomaterials.2012.10.056

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Theranostic nanoparticles for cancer and cardiovascular applications.

Authors:  Dan Wang; Bingbing Lin; Hua Ai
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

2.  Biocompatible ι-carrageenan-γ-maghemite nanocomposite for biomedical applications - synthesis, characterization and in vitro anticancer efficacy.

Authors:  Maya Raman; Viswambari Devi; Mukesh Doble
Journal:  J Nanobiotechnology       Date:  2015-03-03       Impact factor: 10.435

Review 3.  Superparamagnetic Nanoparticles for Atherosclerosis Imaging.

Authors:  Fernando Herranz; Beatriz Salinas; Hugo Groult; Juan Pellico; Ana V Lechuga-Vieco; Riju Bhavesh; J Ruiz-Cabello
Journal:  Nanomaterials (Basel)       Date:  2014-06-05       Impact factor: 5.076

4.  Bovine Serum Albumin-Conjugated Ferrimagnetic Iron Oxide Nanoparticles to Enhance the Biocompatibility and Magnetic Hyperthermia Performance.

Authors:  Viveka Kalidasan; Xiao Li Liu; Tun Seng Herng; Yong Yang; Jun Ding
Journal:  Nanomicro Lett       Date:  2015-10-15

Review 5.  Cyclodextrin-Based Contrast Agents for Medical Imaging.

Authors:  Yurii Shepelytskyi; Camryn J Newman; Vira Grynko; Lauren E Seveney; Brenton DeBoef; Francis T Hane; Mitchell S Albert
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

6.  SEC Separation of Polysaccharides Using Macroporous Spherical Silica Gel as a Stationary Phase.

Authors:  Tomasz Krawczyk; Mariusz Zalewski; Anna Janeta; Paweł Hodurek
Journal:  Chromatographia       Date:  2018-08-06       Impact factor: 2.044

Review 7.  Theranostic Nanomedicine for Malignant Gliomas.

Authors:  Michele d'Angelo; Vanessa Castelli; Elisabetta Benedetti; Andrea Antonosante; Mariano Catanesi; Reyes Dominguez-Benot; Giuseppina Pitari; Rodolfo Ippoliti; Annamaria Cimini
Journal:  Front Bioeng Biotechnol       Date:  2019-11-14

8.  Folic Acid-Decorated β-Cyclodextrin-Based Poly(ε-caprolactone)-dextran Star Polymer with Disulfide Bond-Linker as Theranostic Nanoparticle for Tumor-Targeted MRI and Chemotherapy.

Authors:  Huikang Yang; Nianhua Wang; Ruimeng Yang; Liming Zhang; Xinqing Jiang
Journal:  Pharmaceutics       Date:  2021-12-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.